Reinhart P H, Levitan I B
Department of Neurobiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Neurosci. 1995 Jun;15(6):4572-9. doi: 10.1523/JNEUROSCI.15-06-04572.1995.
Type-2 calcium-dependent potassium (KCa) channels from mammalian brain, reconstituted into planar phospholipid bilayers, are modulated by ATP or ATP analogs via an endogenous protein kinase activity intimately associated with the channel (Chung et al., 1991). We show here that the endogenous protein kinase activity is protein kinase C (PKC)-like because (1) modulation by ATP can be mimicked by exogenous PKC, and (2) the effects of ATP can be blocked by PKC(19-36), a specific peptide inhibitor of PKC. Furthermore, adding the PKC inhibitor peptide after the addition of ATP reverses the modulation produced by ATP, suggesting that there is a phosphoprotein phosphatase activity closely associated with type-2 KCa channels. Consistent with this idea is the finding that microcystin, a non-specific phosphatase inhibitor, enhances the modulation of KCa channel activity by ATP. Inhibitor-1, a specific protein inhibitor of phosphoprotein phosphatase-1, also enhances the effect of ATP, suggesting that the endogenous phosphatase activity is phosphatase-1-like. The results imply that type-2 KCa channels exist as part of a regulatory complex that includes a PKC-like protein kinase and a phosphatase-1-like phosphoprotein phosphatase, both of which participate in the modulation of channel function.
将来自哺乳动物大脑的2型钙依赖性钾(KCa)通道重组到平面磷脂双分子层中,该通道可通过与通道紧密相关的内源性蛋白激酶活性被ATP或ATP类似物调节(Chung等人,1991年)。我们在此表明,内源性蛋白激酶活性类似于蛋白激酶C(PKC),因为(1)ATP的调节作用可被外源性PKC模拟,并且(2)ATP的作用可被PKC(19 - 36)阻断,PKC(19 - 36)是PKC的一种特异性肽抑制剂。此外,在添加ATP后添加PKC抑制剂肽可逆转ATP产生的调节作用,这表明存在一种与2型KCa通道紧密相关的磷蛋白磷酸酶活性。与此观点一致的是,微囊藻毒素(一种非特异性磷酸酶抑制剂)增强了ATP对KCa通道活性的调节作用这一发现。抑制剂 - 1(磷蛋白磷酸酶 - 1的一种特异性蛋白抑制剂)也增强了ATP的作用,这表明内源性磷酸酶活性类似于磷酸酶 - 1。结果表明,2型KCa通道作为一种调节复合物的一部分存在,该复合物包括一种类似于PKC的蛋白激酶和一种类似于磷酸酶 - 1的磷蛋白磷酸酶,二者均参与通道功能的调节。